QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MNKD

QT86MannKind Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
3.94
+0.02+0.51%
OverviewShort InterestFilings
MNKDQT86MannKind Corporation·NASDAQ
OverviewShort InterestFilings
3.94+0.51%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.08
Insider Own4.40%
Shs Outstand308.95M
Perf Week5.07%
Market Cap1.21BForward P/E27.65EPS next Y0.14Insider Trans0.01%Shs Float-Perf Month33.11%
Enterprise Value1.59BPEG0.28EPS next Q-0.02Inst Own-Short Float-Perf Quarter56.35%
Income-23979476.00P/S3.36EPS this Y78.13%Inst Trans-Short Ratio-Perf Half Y-33.33%
Sales360.79MP/B-EPS next Y914.29%ROA-3.21%Short Interest-Perf YTD-30.51%
Book/sh-0.19P/C64.16EPS next 5Y-ROE45.59%52W High6.51 -39.48%Perf Year5.07%
Cash/sh0.43P/FCF95.23EPS past 3/5Y-ROIC1.80%52W Low2.23 76.68%Perf 3Y-
Dividend Est.-EV/EBITDA57.89Sales past 3/5Y51.68% 39.95%Gross Margin75.96%Volatility3.61% 4.05%Perf 5Y-
Dividend TTM-EV/Sales4.42EPS Y/Y TTM-169.81%Oper. Margin3.71%ATR (14)0.22Perf 10Y-
Dividend Ex-Date-Quick Ratio1.50Sales Y/Y TTM26.22%Profit Margin-6.63%RSI (14)64.30Recom2.33
Dividend Gr. 3/5Y-Current Ratio1.87EPS Q/Q-SMA209.22%Beta1.14Target Price8.50
Payout0.00%Debt/Eq-7.38Sales Q/Q15.38%SMA5022.90%Rel Volume2.91Prev Close3.92
Employees403LT Debt/Eq-8.31EarningsAug 05SMA200-13.09%Avg Volume5.71MPrice3.94
IPO DateJul 28, 2004Option/ShortYes / YesEPS/Sales Surpr.-150.00% -14.29%Net Debt/EBITDA13.93Volume16,619,873Change0.51%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-01-26ReiteratedWells FargoOverweight$10 → $11
May-07-26ReiteratedMizuho Securities$8.00 → $7.00
May-07-26ReiteratedH.C. Wainwright$8.00 → $10
May-07-26ReiteratedWells FargoOverweight$10
Apr-13-26ReiteratedMizuho Securities$10 → $8.00
Apr-08-26ReiteratedTruist Financial$7.00 → $6.00
Feb-27-26DowngradeRBC CapitalOutperform → Sector Perform
Nov-24-25InitiatedTruistBuy$9.00
Sep-02-25ReiteratedH.C. Wainwright$9.00 → $11
Aug-26-25ReiteratedRBC CapitalOutperform$8.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue361349286
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A876177
Gross Profit274288209
Selling, General and Administrative Excl. Other17314494
Research and Development736646
Other Operating Expense1539-4
Operating Income133973
Interest Expense381438
Unusual Expense
———
Non-Operating Income (Expense)3244
Net Income Before Taxes-28131
Income Taxes-5-43
Consolidated Net Income-24628
Net Income From Continuing Operations-24628
Net Income-24628
EPS (Recurring)-0.080.020.10
EPS (Basic, Before Extraordinaries)-0.080.020.10
EPS (Diluted)-0.080.020.10
EBITDA272877
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio—283.50—
Price To Sales Ratio3.364.97—
Gross Margin75.9082.5273.08
Operating Margin3.6011.1725.52
Net Margin-6.651.729.79
Shares Outstanding308306274
Market Capitalization1,2141,735—
Operating Lease Expense
———
Insider Trading Volume
$4.12$3.92$3.72$3.52$3.32● Close Price0.00M0.49M0.97M1.46M1.95MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Binder Steven B.DirectorMay 12 '26Sale3.2916,94055,733808,008May 13 12:00 AM
Thomson DavidEVP Genl Counsel & SecretaryMay 12 '26Sale3.293,0339,979826,299May 13 12:00 AM
Castagna MichaelChief Executive OfficerMar 10 '26Buy2.59100,000259,0002,575,911Mar 10 12:00 AM
Tross Stuart AChief People & Workpl OfficerJan 08 '26Sale6.3347,006297,548985,007Jan 09 12:00 AM
Castagna MichaelChief Executive OfficerDec 17 '25Option Exercise4.55115,804526,9082,570,596Dec 19 12:00 AM
Castagna MichaelChief Executive OfficerDec 17 '25Sale6.0165,804395,4822,504,792Dec 19 12:00 AM
Castagna MichaelChief Executive OfficerDec 16 '25Option Exercise4.5542,620193,9222,526,102Dec 16 12:00 AM
Castagna MichaelChief Executive OfficerDec 16 '25Sale6.0021,310127,8602,504,792Dec 16 12:00 AM
Castagna MichaelChief Executive OfficerDec 12 '25Option Exercise4.5541,612189,3342,525,598Dec 16 12:00 AM
Thomson DavidEVP Genl Counsel & SecretaryDec 02 '25Option Exercise4.58255,5601,171,576989,499Dec 04 12:00 AM
Castagna MichaelChief Executive OfficerDec 02 '25Option Exercise4.55215,840982,0722,612,712Dec 04 12:00 AM
Castagna MichaelChief Executive OfficerDec 02 '25Sale5.57107,920601,1142,504,792Dec 04 12:00 AM
Thomson DavidEVP Genl Counsel & SecretaryDec 02 '25Sale5.57147,780823,135841,719Dec 04 12:00 AM
Singh Sanjay REVP Technical OperationsNov 14 '25Sale5.0318,77794,448455,211Nov 14 12:00 AM
Tross Stuart AChief People & Workpl OfficerSep 16 '25Sale5.3447,000250,9801,032,013Sep 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR